慢性阻塞性肺部疾病患者的身体活动,久坐行为和睡眠障碍之间的关联:一项跨部分研究
Xianghui Ma1, Qing Zhang2, Xigang Gao3
1Department of Rheumatology, Dongying City People's Hospital, Dongying, Shandong Province, 257091, People's Republic of China.
概括
每天坐着的时间显著增加了COPD患者的睡眠障碍风险. 休时间的体力活动没有显示出显著的相关性. 减少久坐不动行为是控制COPD睡眠问题的关键.
科学领域:
- 肺部医学 肺部医学
- 睡眠医学 睡眠医学
- 公共卫生 公共卫生
背景情况:
- 睡眠障碍是慢性阻塞性肺病 (COPD) 患者经常出现的并发症.
- 了解身体活动和久坐行为等生活方式因素对COPD睡眠质量的影响,对于有效管理至关重要.
- 以前的研究还没有完全阐明日常坐着时间和休时间的体力活动与这一群体睡眠障碍之间的具体关联.
研究的目的:
- 调查每日坐时间 (DST) 和休时间体力活动 (LTPA) 与被诊断患有COPD的个体睡眠障碍的患病率之间的潜在关联.
- 量化COPD患者与不同水平的久坐行为和体力活动参与相关的睡眠障碍风险.
主要方法:
- 来自2063名COPD患者的数据使用国家健康和营养检查调查 (NHANES) 数据库 (2007-2012) 进行分析.
- 全球体力活动问卷数据被用于评估DST和LTPA.
- 使用加权双项逻辑回归模型来确定DST,LTPA和睡眠障碍之间的关联的几率比率 (OR) 和95%置信区间 (CI).
主要成果:
- 在较长的久坐时间 (DST>6h和DST>8h) 与睡眠障碍风险增加之间发现了显著的相关性.
- 休时间的体力活动 (LTPA <150分钟/周) 与睡眠障碍没有显著的关联.
- 与LTPA≥150分钟/周和DST<4小时的患者相比,COPD患者的LTPA<150分钟/周和DST>8小时的睡眠障碍风险是5.88倍.
结论:
- 久坐不动的行为,特别是每天长时间的坐着时间,在COPD患者中独立地与更高的睡眠障碍风险有关.
- 虽然LTPA没有显示直接相关性,但低LTPA和高DST的组合显著增加睡眠障碍风险.
- 促进增加光强度身体活动和监督炼计划的干预措施可能有助于预防COPD患者的睡眠障碍.
相关概念视频
Sleep Apnea
114
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
114
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Other Pulmonary Disorders
782
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
782
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
117
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
117
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


